X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (35) 35
index medicus (26) 26
male (26) 26
female (24) 24
middle aged (21) 21
aged (20) 20
gastroenterology & hepatology (16) 16
adult (15) 15
treatment outcome (10) 10
aged, 80 and over (9) 9
risk factors (9) 9
hepatocellular carcinoma (8) 8
antiviral agents - therapeutic use (7) 7
carcinoma, hepatocellular - epidemiology (6) 6
genotype (6) 6
hepatitis (6) 6
hepatitis c, chronic - drug therapy (6) 6
induced pluripotent stem cells - metabolism (6) 6
japan - epidemiology (6) 6
liver cancer (6) 6
risk (6) 6
time factors (6) 6
abridged index medicus (5) 5
cell line (5) 5
cirrhosis (5) 5
deoxyribonucleic acid--dna (5) 5
dna methylation (5) 5
incidence (5) 5
patients (5) 5
peripheral vascular disease (5) 5
prognosis (5) 5
adolescent (4) 4
alanine transaminase - blood (4) 4
cancer (4) 4
carcinoma, hepatocellular - virology (4) 4
cell differentiation - physiology (4) 4
differentiation (4) 4
dna (4) 4
genetics (4) 4
genomics (4) 4
genotype & phenotype (4) 4
hepacivirus - isolation & purification (4) 4
hepatitis c (4) 4
induced pluripotent stem cells - cytology (4) 4
infections (4) 4
interferon (4) 4
liver neoplasms - epidemiology (4) 4
mice (4) 4
original paper (4) 4
radiology, nuclear medicine & medical imaging (4) 4
retrospective studies (4) 4
ribavirin (4) 4
science (4) 4
therapy (4) 4
virology (4) 4
young adult (4) 4
age factors (3) 3
analysis (3) 3
animals (3) 3
antiviral agents - administration & dosage (3) 3
article (3) 3
biology (3) 3
carcinoma, hepatocellular - mortality (3) 3
cell differentiation - genetics (3) 3
deoxyribonucleic acid (3) 3
diagnosis (3) 3
efficacy (3) 3
embryonic stem cells - cytology (3) 3
embryonic stem cells - metabolism (3) 3
epigenesis, genetic (3) 3
epigenetics (3) 3
gene expression (3) 3
gene-expression (3) 3
genotypes (3) 3
hepacivirus - classification (3) 3
hepacivirus - genetics (3) 3
hepatitis c virus (3) 3
hepatitis c, chronic - complications (3) 3
hepatology (3) 3
hepatoma (3) 3
human immunodeficiency virus--hiv (3) 3
infection (3) 3
japan (3) 3
liver (3) 3
liver diseases (3) 3
liver neoplasms - mortality (3) 3
liver neoplasms - virology (3) 3
methylation (3) 3
multivariate analysis (3) 3
mutation (3) 3
oncology (3) 3
prevalence (3) 3
radiology (3) 3
risk assessment (3) 3
serum (3) 3
severity of illness index (3) 3
sofosbuvir (3) 3
stem cells (3) 3
surgery (3) 3
tumors (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Infectious Diseases, The, ISSN 1473-3099, 2015, Volume 15, Issue 6, pp. 645 - 653
Summary Background Compared with other countries, patients with chronic hepatitis C infection in Japan tend to be older, have more advanced liver disease, and... 
Infectious Disease | INFECTIOUS DISEASES | SIMEPREVIR | INFECTION | CHRONIC HCV | Uridine Monophosphate - administration & dosage | Humans | Middle Aged | Hepacivirus - genetics | Hepatitis C, Chronic - virology | Male | Drug-Related Side Effects and Adverse Reactions - pathology | Young Adult | Benzimidazoles - administration & dosage | Time Factors | Ribavirin - administration & dosage | Aged, 80 and over | Adult | Female | Fluorenes - administration & dosage | Fluorenes - adverse effects | Uridine Monophosphate - adverse effects | Benzimidazoles - adverse effects | Hepacivirus - isolation & purification | Administration, Oral | Japan | Genotype | Treatment Outcome | Hepatitis C, Chronic - drug therapy | Antiviral Agents - administration & dosage | Drug-Related Side Effects and Adverse Reactions - epidemiology | Asian Continental Ancestry Group | Ribavirin - adverse effects | Antiviral Agents - adverse effects | Uridine Monophosphate - analogs & derivatives | Aged | Hepacivirus - classification | Sofosbuvir | Care and treatment | Liver | Dosage and administration | Product development | Drug therapy, Combination | Hepatitis C virus | Hepatitis C | Health aspects | Ribavirin | Hepatitis | Genotype & phenotype | Liver cancer | Heart attacks | Liver diseases | Human immunodeficiency virus--HIV | Hepatology | Response rates | Interferon | Infections | Drug dosages | Patients
Journal Article
Surgery: Official Journal of the Society of University Surgeons, Central Surgical Association, and the American Association of Endocrine Surgeons, ISSN 0039-6060, 2015, Volume 157, Issue 4, pp. 699 - 707
Journal Article
Journal of Vascular and Interventional Radiology, ISSN 1051-0443, 2012, Volume 23, Issue 3, pp. 317 - 322.e1
Journal Article
Annals of Thoracic Surgery, ISSN 0003-4975, 2009, Volume 87, Issue 3, pp. 954 - 955
We report a case in which the common trunk of the left pulmonary vein was injured incidentally due to a misunderstanding of the anatomy. After cutting the... 
Surgery | Cardiothoracic Surgery | SURGERY | VENOUS DRAINAGE | CARDIAC & CARDIOVASCULAR SYSTEMS | RESECTION | RESPIRATORY SYSTEM | COMPUTED-TOMOGRAPHY | Pulmonary Veins - abnormalities | Humans | Middle Aged | Intraoperative Complications - surgery | Lung Neoplasms - surgery | Male | Pulmonary Veins - surgery | Pulmonary Veins - injuries | Lung cancer
Journal Article
Journal Article
Hepatology, ISSN 0270-9139, 02/2018, Volume 67, Issue 2, pp. 505 - 513
Glecaprevir (nonstructural protein 3/4A protease inhibitor) and pibrentasvir (nonstructural protein 5A inhibitor) (G/P), a coformulated once‐daily, all oral,... 
ASIA | SOFOSBUVIR | CIRRHOSIS | PHASE-3 TRIAL | PREVALENCE | RIBAVIRIN | GASTROENTEROLOGY & HEPATOLOGY | BURDEN | Cirrhosis | Antiretroviral drugs | Hepatitis | Chronic infection | Infections | Interferon | Safety | Hepatitis C | Patients | Ribavirin | Genotypes | Original
Journal Article
Hepatology, ISSN 0270-9139, 04/2013, Volume 57, Issue 4, pp. 1407 - 1415
The response rate to sorafenib in hepatocellular carcinoma (HCC) is relatively low (0.7%‐3%), however, rapid and drastic tumor regression is occasionally... 
GROWTH-FACTOR RECEPTOR | GEFITINIB | GENE | GASTRIC-CANCER | MUTATIONS | COMPARATIVE GENOMIC HYBRIDIZATION | ANTITUMOR-ACTIVITY | GASTROENTEROLOGY & HEPATOLOGY | CLINICAL-RESPONSE | FEATURES | Niacinamide - analogs & derivatives | Carcinoma, Hepatocellular - epidemiology | Humans | Middle Aged | Male | Transplantation, Heterologous | Antineoplastic Agents - therapeutic use | Carcinoma, Hepatocellular - secondary | Incidence | Fibroblast Growth Factor 4 - genetics | Lung Neoplasms - secondary | Aged, 80 and over | Adult | Female | Fibroblast Growth Factor 3 - metabolism | Liver Neoplasms - pathology | Antineoplastic Agents - pharmacology | Retrospective Studies | Gene Expression Regulation, Neoplastic - drug effects | Fibroblast Growth Factor 4 - metabolism | Gene Expression Regulation, Neoplastic - genetics | Fibroblast Growth Factor 3 - genetics | Liver Neoplasms - drug therapy | Niacinamide - therapeutic use | Phenylurea Compounds - therapeutic use | Treatment Outcome | DNA, Neoplasm - drug effects | Gene Amplification - drug effects | Animals | Lung Neoplasms - epidemiology | Mice, Nude | Cell Line, Tumor | Aged | Gene Amplification - genetics | Mice | Mice, Inbred BALB C | Phenylurea Compounds - pharmacology | DNA, Neoplasm - genetics | Niacinamide - pharmacology | In Vitro Techniques | Liver cancer | Hepatology | Tumors
Journal Article
British Journal of Cancer, ISSN 0007-0920, 02/2017, Volume 116, Issue 4, pp. 448 - 454
Journal Article
Journal Article
Gut, ISSN 0017-5749, 03/2018, Volume 67, Issue 3, pp. 473 - 484
ObjectiveTo discover and confirm blood-based colon cancer early-detection markers.DesignWe created a high-density antibody microarray to detect differences in... 
Colorectal Cancer | Tumour Markers | Colorectal Adenomas | Colorectal Cancer Screening | BREAST-CANCER | MORTALITY | DIAGNOSIS | BIOMARKER | COLORECTAL-CANCER | SERUM | SAMPLES | GASTROENTEROLOGY & HEPATOLOGY | DISCOVERY | CA-19-9 | ACCURACY | Early Detection of Cancer - methods | Adaptor Proteins, Signal Transducing - blood | Humans | Middle Aged | Colonic Neoplasms - diagnosis | Male | Hyaluronan Receptors - blood | Cytokine Receptor gp130 - blood | Lewis X Antigen - metabolism | Case-Control Studies | Colonic Neoplasms - metabolism | Adenoma - metabolism | Hyaluronan Receptors - metabolism | Aged, 80 and over | Biomarkers, Tumor - metabolism | Adult | Female | ErbB Receptors - blood | von Willebrand Factor - metabolism | Adenoma - diagnosis | ErbB Receptors - metabolism | Cytokine Receptor gp130 - metabolism | Oligosaccharides - metabolism | Biomarkers, Tumor - blood | Adenoma - blood | CA-19-9 Antigen - metabolism | Colonic Neoplasms - blood | Protein Array Analysis | Aged | Adaptor Proteins, Signal Transducing - metabolism | Immunohistochemistry | Plasma | Colorectal cancer | Cardiovascular disease | Immunoblotting | Adenoma | Ovarian cancer | Proteins | Interleukin 6 | Epidermal growth factor | Colon cancer | CD44 antigen | Colonoscopy | Von Willebrand factor | DNA methylation | Population | Endoscopy | Colon | Age | Deoxyribonucleic acid--DNA | Antigens | Cytokines | Epidermal growth factor receptors | Mortality | Antibody microarrays | Breast cancer | FDA approval | Medical screening | Womens health | Medical prognosis | Biomarkers | Health risk assessment | Arrays | Tumors
Journal Article
Journal Article